Sinopharm Group Co. Ltd.
SHTDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $56,713 | $58,028 | $54,455 | $44,663 |
| - Cash | $54,313 | $63,809 | $55,222 | $43,529 |
| + Debt | $76,386 | $73,782 | $69,590 | $68,368 |
| Enterprise Value | $78,785 | $68,002 | $68,824 | $69,502 |
| Revenue | $584,508 | $596,570 | $552,148 | $521,051 |
| % Growth | -2% | 8% | 6% | – |
| Gross Profit | $44,255 | $48,512 | $47,434 | $44,051 |
| % Margin | 7.6% | 8.1% | 8.6% | 8.5% |
| EBITDA | $20,175 | $26,899 | $26,249 | $24,682 |
| % Margin | 3.5% | 4.5% | 4.8% | 4.7% |
| Net Income | $7,050 | $9,054 | $8,526 | $7,759 |
| % Margin | 1.2% | 1.5% | 1.5% | 1.5% |
| EPS Diluted | 2.26 | 2.9 | 2.73 | 2.49 |
| % Growth | -22.1% | 6.2% | 9.6% | – |
| Operating Cash Flow | $11,546 | $17,173 | $20,964 | $9,308 |
| Capital Expenditures | -$1,968 | -$2,336 | -$2,418 | -$2,256 |
| Free Cash Flow | $9,578 | $14,837 | $18,546 | $7,052 |